rs41292143

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_017739.4(POMGNT1):​c.1257G>A​(p.Leu419Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,614,166 control chromosomes in the GnomAD database, including 266 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L419L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.010 ( 12 hom., cov: 32)
Exomes 𝑓: 0.017 ( 254 hom. )

Consequence

POMGNT1
NM_017739.4 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.268

Publications

7 publications found
Variant links:
Genes affected
POMGNT1 (HGNC:19139): (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)) This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014]
TSPAN1 (HGNC:20657): (tetraspanin 1) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017739.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 1-46192545-C-T is Benign according to our data. Variant chr1-46192545-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.268 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0102 (1553/152306) while in subpopulation NFE AF = 0.0185 (1258/68024). AF 95% confidence interval is 0.0176. There are 12 homozygotes in GnomAd4. There are 665 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017739.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT1
NM_017739.4
MANE Select
c.1257G>Ap.Leu419Leu
synonymous
Exon 15 of 22NP_060209.4Q8WZA1-1
POMGNT1
NM_001243766.2
c.1257G>Ap.Leu419Leu
synonymous
Exon 15 of 23NP_001230695.2Q8WZA1-2
POMGNT1
NM_001410783.1
c.1257G>Ap.Leu419Leu
synonymous
Exon 15 of 22NP_001397712.1A0A8I5KNB7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT1
ENST00000371984.8
TSL:1 MANE Select
c.1257G>Ap.Leu419Leu
synonymous
Exon 15 of 22ENSP00000361052.3Q8WZA1-1
POMGNT1
ENST00000371992.1
TSL:2
c.1257G>Ap.Leu419Leu
synonymous
Exon 15 of 23ENSP00000361060.1Q8WZA1-2
POMGNT1
ENST00000692369.1
c.1257G>Ap.Leu419Leu
synonymous
Exon 15 of 22ENSP00000508453.1A0A8I5KNB7

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1552
AN:
152190
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00352
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00497
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0185
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00889
AC:
2234
AN:
251268
AF XY:
0.00885
show subpopulations
Gnomad AFR exome
AF:
0.00308
Gnomad AMR exome
AF:
0.00301
Gnomad ASJ exome
AF:
0.00755
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00310
Gnomad NFE exome
AF:
0.0161
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.0168
AC:
24564
AN:
1461860
Hom.:
254
Cov.:
31
AF XY:
0.0162
AC XY:
11787
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00218
AC:
73
AN:
33480
American (AMR)
AF:
0.00344
AC:
154
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00685
AC:
179
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00205
AC:
177
AN:
86258
European-Finnish (FIN)
AF:
0.00436
AC:
233
AN:
53398
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0207
AC:
23004
AN:
1112004
Other (OTH)
AF:
0.0122
AC:
738
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2039
4078
6116
8155
10194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1553
AN:
152306
Hom.:
12
Cov.:
32
AF XY:
0.00893
AC XY:
665
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00351
AC:
146
AN:
41550
American (AMR)
AF:
0.00497
AC:
76
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4826
European-Finnish (FIN)
AF:
0.00301
AC:
32
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0185
AC:
1258
AN:
68024
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
80
159
239
318
398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0136
Hom.:
6
Bravo
AF:
0.00983
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0164
EpiControl
AF:
0.0173

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
not provided (3)
-
-
1
Autosomal recessive limb-girdle muscular dystrophy type 2O (1)
-
-
1
Congenital Muscular Dystrophy, alpha-dystroglycan related (1)
-
-
1
Muscle eye brain disease (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
5.8
DANN
Benign
0.67
PhyloP100
-0.27
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41292143;
hg19: chr1-46658217;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.